Farber's Brian Wolpin, MD, MPH, will present positive results from the RASolute 302 trial showing a substantial prolongation of survival for patients with previously treated metastatic pancreatic ...

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of ...

The experimental drug daraxonrasib, which doubled survival time in patients with advanced pancreatic cancer, may also prove effective for lung, colon and ovarian cancers.

The highly anticipated results of a clinical trial for the pill, daraxonrasib, have been released, giving doctors hope for ...

Cancer survivors who practiced yoga reported improvements in mood, anxiety and fatigue compared to standard care alone, a clinical trial found.

The Cancer Center at Illinois was officially designated as a Basic Cancer Center by the National Cancer Institute last month.

Regions with high death rates are often called high cancer burden areas. For the past 20 years, for all cancers combined and for several of the most common types of cancer the cancer burden areas have ...

Duke Health is moving ahead with building a gastrointestinal endoscopy center in Cary after a years-long delay.

Professional antigen-presenting cells—monocytes and macrophages—engulf these proteins, digest them into short peptide ...

University of Virginia School of Medicine scientists have revealed how mistakes in the final step of cell division can have ...

FDA approval brings Enhertu into early breast cancer treatment, boosting response before surgery and cutting recurrence risk ...

Dallas Mavericks star Cooper Flagg's season ended last month, but that hasn’t stopped him from making big plays. Flagg confirmed his relationship with Duke women’s basketball center Arianna Roberson ...